Biohaven eyes mid-2021 for migraine prevention drug launch

"I hope that in 6 months or so from now that we will be the first oral CGRP with the indication for the prevention of migraine," Biohaven CEO Vlad Coric said.

source https://www.cnbc.com/2020/11/18/biohaven-eyes-mid-2021-for-migraine-prevention-drug-launch-.html

Post a Comment

0 Comments